China Shineway Pharmaceutical Group Limited (HKG:2877)

HKG:2877 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,478	7,290	5,492	5,733	5,205	4,007
Market Cap Growth	3.45%	32.74%	-4.22%	10.16%	29.89%	-29.80%
Enterprise Value	225	967	24	537	224	200
Last Close Price	9.90	9.04	6.39	6.30	5.37	3.79
PE Ratio	8.27	8.15	5.14	7.02	7.62	11.44
Forward PE	8.04	6.29	5.10	7.57	6.45	6.41
PS Ratio	2.04	1.81	1.10	1.28	1.32	1.27
PB Ratio	0.87	0.92	0.71	0.80	0.72	0.58
P/TBV Ratio	0.90	0.94	0.73	0.82	0.75	0.60
P/FCF Ratio	8.54	8.32	6.32	5.17	6.96	5.89
P/OCF Ratio	7.07	7.11	5.35	4.57	6.03	5.28
EV/Sales Ratio	0.06	0.24	0.01	0.12	0.06	0.06
EV/EBITDA Ratio	0.29	1.02	0.02	0.54	0.26	0.27
EV/EBIT Ratio	0.32	1.09	0.02	0.67	0.34	0.40
EV/FCF Ratio	0.26	1.10	0.03	0.48	0.30	0.29
Debt / Equity Ratio	0.04	0.05	0.04	0.00	0.00	0.07
Debt / EBITDA Ratio	0.48	0.38	0.29	0.01	0.02	0.62
Debt / FCF Ratio	0.43	0.42	0.38	0.01	0.02	0.69
Asset Turnover	0.33	0.39	0.51	0.51	0.45	0.37
Inventory Turnover	1.15	1.11	1.44	1.63	1.58	1.53
Quick Ratio	3.36	3.17	2.97	3.66	4.62	3.96
Current Ratio	3.69	3.51	3.35	4.07	5.19	4.62
Return on Equity (ROE)	10.94%	11.59%	14.45%	11.77%	9.52%	5.10%
Return on Assets (ROA)	3.98%	5.33%	6.81%	5.78%	4.63%	3.68%
Return on Invested Capital (ROIC)	5.10%	6.90%	8.83%	7.25%	5.52%	4.27%
Return on Capital Employed (ROCE)	8.10%	11.00%	13.60%	10.90%	8.80%	7.00%
Earnings Yield	12.14%	12.26%	19.45%	14.25%	13.13%	8.74%
FCF Yield	11.71%	12.02%	15.81%	19.33%	14.37%	16.97%
Dividend Yield	5.22%	6.35%	7.24%	5.75%	8.92%	10.02%
Payout Ratio	42.87%	48.56%	32.73%	33.45%	81.39%	58.83%
Buyback Yield / Dilution	-	-	-	-0.03%	0.21%	3.10%
Total Shareholder Return	5.22%	6.35%	7.24%	5.71%	9.13%	13.12%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.